Low Volume PEG With Low Residue Test Meals Versus High Volume Split-dose PEG Bowel Preparation
NCT ID: NCT01568814
Last Updated: 2012-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
188 participants
INTERVENTIONAL
2012-01-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
NCT01685970
Efficacy of Tailored Bowel Preparation Strategy Guided by a Predictive Model
NCT03142854
Efficacy of Tailored Bowel Preparation Strategy: A Randomized Controlled Study
NCT03765216
Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy
NCT02124447
The Effect of 1L Polyethylene Glycol Plus Ascorbic Acid With Prepackaged Low-Residue Diet for Bowel Preparation
NCT03329339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Entry criteria: Entry criteria: Adult outpatients and inpatients (18-85 years of age) who undergo colonoscopy for screening, cancer surveillance or with gastrointestinal symptoms, other symptoms
Primary Outcome: Quality of bowel preparation (Ottawa scale) Secondary Outcome: Tolerability (preparation completion, side effect), acceptance, willingness
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High volume PEG
Patients who are scheduled colonoscopy ingest high volume PEG(4L) for bowel preparation.
high volume PEG
high volume polyethylene glycol 4 lilter split-dosing 2L/2L two times
Low volume PEG with low residual meals
Patients who are scheduled colonoscopy ingest low volume PEG(2L) and have a prepackaged low residual meals for bowel preparation.
Low volume PEG
low volume polyethylene glycol 2 liter one time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low volume PEG
low volume polyethylene glycol 2 liter one time
high volume PEG
high volume polyethylene glycol 4 lilter split-dosing 2L/2L two times
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Breast feeding
* Prior history of surgical large bowel resection
* Severe medical condition such as severe cardiac
* Hepatic, renal failure (creatinine ≥ 3.0mg/dL (normal 0.8-1.4))
* Drug addiction or major psychiatric illness
* Suspected bowel obstruction or ileus
* Allergy to PEG
* Refusal of consent to participate in the study.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inje University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Hee Seo, MD
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haeundae Paik Hospital, Inje University School of Medicine
Busan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.0-A2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.